CRH Medical Corporation (AMEX:CRHM) is reporting second quarter earnings results on Monday 10th August 2020, after market close.
Previous Quarter Performance
CRH Medical Corporation came out with loss for the first quarter of $ 0.03 per share, from the revenue of $ 25.45 million. The consensus estimates are income of $ 0.04 per share from $ 27.81 million in revenue. The bottom line results missed street analysts by $ 0.07 or 175 percent, at the same time, top line results fell short of analysts by $ 2.36 million or 8.49 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of CRH Medical Corporation
Stock Performance
According to the previous trading day, closing price of CRHM was $ 2.40, representing a 179.07 % increase from the 52 week low of $ 0.86 and a 45.82 % decrease over the 52 week high of $ 4.43.
The company has a market capital of $ 172.63 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”CRHM” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH ORegan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.
